ISTH Congress Abstracts

Official abstracts site for the ISTH Congress

MENU 
  • Home
  • Congress Archive
    • ISTH 2022 Congress
    • ISTH 2021 Congress
    • ISTH 2020 Congress
  • Resources
  • Search

ISTH 2022 Congress

Acquired Bleeding Disorders » Management/Treatments of Acquired Bleeding

Theme Navigation

  • ISTH 2022 Congress
    • Acquired Bleeding Disorders
      • Management/Treatments of Acquired Bleeding

Abstract Number: PB0988

A TEG-guided treatment algorithm for major surgical bleeding

S. Dawson1, A. Cain2

Abstract Number: PB0989

Acquired Factor V Inhibitor In a Patient With Metastatic Cancer

D. Dhami1, P. Changizzadeh2, C. Solowiej Singh3, S. Dhami4, S. Muttana5

Abstract Number: PB0990

Acquired FXI deficiency (aFXIdef) in a HIV + patient with SLE. Alternative evolution to lupus Anticoagulant (LA) during immunosuppressive therapy.

C. Seehaus1, M. Lopez2, L. Barrera3, P. Quiñones Maffassanti4, L. Ferreyra Garrott5, V. Privitera6, F. Chuliber7, D. Penchasky8, E. Viñuales8, J. Arbelbide8, M. Martinuzzo9

Abstract Number: PB0005

Acquired haemophilia presenting in a 14-year-old girl

J. Roganovic

Abstract Number: VPB0003

Acquired von Willebrand syndrome in patients with monoclonal gammopathy: a single centre experience.

M. Costa-Pinto1, M. Fernández2, N. Rodríguez2, A. Pérez-Rodríguez2, M. Gómez-del-Castillo2, T. Lado2, M. Lopez-Fernandez3

Abstract Number: VPB0997

Analytical performance of different laboratory methods for measuring susoctog-alpha

C. Novembrino1, I. Quaglia2, M. Boscolo-Anzoletti3, E. Galbiati3, E. Dosio4, A. Valpreda4

Abstract Number: PB0991

Assessment of Interference by Emicizumab in the Measurement of Susoctocog Alfa Factor VIII Activity Using a Chromogenic Assay

L. Pan1, A. Mokdad2, P. Turecek3, M. Robinson4, N. Jain1

Abstract Number: PB0985

Clinical experience in factor Xa inhibitors´ reversal with prothrombin complex concentrate in emergency settings

J. Cerezo Martín1, G. Mendez2, I. Romon2, B. González-Mesones2, M. gonzalez2, M. Pérez2, S. Fernández-Luis2, E. Ocio2

Abstract Number: PB0006

Delayed Diagnosis of Acquired Hemophilia A Results in Worse Clinical Outcome

S. Stankovikj1, n. Ridova2, s. Stojanovska2, t. Ristevska2, M. Cvetanoski2

Abstract Number: PB0984

Direct comparison of Andexanet alfa and prothrombin complex concentrates in the reversal of direct factor Xa inhibitors – An in vitro study

H. Brinkman1, M. Zuurveld2, J. Meijers3

Abstract Number: PB0986

Efficacy and safety of prothrombin complex concentrate for major bleeding in patients treated with direct Factor-Xa inhibitors

R. Clapham1, V. Speed2, K. Nwankiti2, R. Byrne1, J. Patel2, J. Czuprynska1, R. Patel2, R. Arya2, L. Roberts1

Abstract Number: PB0002

Emicizumab for the treatment of acquired hemophilia A: an update of the Vienna experience

P. Knöbl1, J. Thaler2, P. Jilma3, P. Quehenberger4, K. Gleixner5, W. Sperr6

Abstract Number: VPB0004

Evaluation of the utility of BAT (ISTH-SSC bleeding assessment tool) questionnaire in the diagnostic of acquired von Willebrand syndrome

M. Costa-Pinto1, M. Fernández2, N. Rodríguez2, A. Pérez-Rodríguez2, M. Gómez-del-Castillo2, T. Lado2, M. Lopez-Fernandez3

Abstract Number: OC 24.4

Factor XIII levels correlate with fibrinogen concentrations in patients with venous malformations and chronic disseminated intravascular coagulopathy

N. Fordham1, J. Clark1, A. Taylor1, K. Sibson1, L. Solman1, M. Glover1, M. Mathias2

Abstract Number: VPB0996

FiiRST-2; a prospective, randomized study of clotting factor concentrates versus standard massive hemorrhage protocol in severely bleeding trauma patients

L. Da Luz1, J. Callum2, A. Beckett3, H. Peng4, P. Engels5, N. Parry6, H. Tien1, A. Nathens1, J. Carroll7, D. Grewal7, K. Karkouti8

Abstract Number: PB0987

Impact of amotosalen/UVA process for pathogen reduction in platelet concentrates on transfusion efficiency in cardiac surgery

B. Belkacem1, H. Hamzeh-Cognasse2, A. Duchez3, M. Eyraud4, C. Arthaud4, A. Prier5, E. Audoux6, T. Ebermeyer7, P. Chavarin4, A. Kazra1, J. Morel8, J. Palao8, F. Cognasse6

Abstract Number: OC 11.3

Improved Survival in Severely Bleeding Trauma Patients Treated with Low-titer Group O Whole Blood Compared to Component Therapy

E. Mihalko*1, S. Shea2, K. Thomas3, M. Huff4, D. Scheurer5, G. Bochicchio6, P. Spinella7

Abstract Number: PB0980

Intravenous Ferric Gluconate Use in Anemic Heart Failure Patients at a Large Academic Medical Center

S. Coriolan, C. Merchan, A. Katz, T. Ahuja

Abstract Number: PB0001

Management of acquired haemophilia A in a Portuguese Center: 16 years and 16 cases

C. Catarino1, F. Rodrigues2, A. Pereira2, J. Pestana3, C. Peixoto4, S. Campaniço4, L. Parusnikova4, C. Correia4, C. Pereira4, E. Parcelas5, J. Lucas6, D. Passos7, S. Croca7, P. Afonso4, P. Morgado7, C. Calisto7, S. Cruz7, M. Carriço7

Abstract Number: PB0993

Measurement of procoagulant platelets in platelet-rich plasma by flow cytometer for the diagnosis of heparin-induced thrombocytopenia

L. Pelzl1, A. Karakuyu2, J. Zlamal3, I. Marini4, A. Singh5, H. Jaffal6, S. Hammer7, K. Althaus1, T. Backchoul3

  • 1
  • 2
  • Next Page »

« View all themes from the ISTH 2022 Congress

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2022 John Wiley & Sons, Inc. All Rights Reserved.
Wiley